NCT06091761Completed
Thread Embedding Acupuncture Combined With Auricular Acupuncture for Overweight and Obesity
Efficacy and Safety of Thread Embedding Acupuncture Combined With Auricular Acupuncture for Overweight and Obesity: Randomized Placebo-Controlled Trial
Source: ClinicalTrials.gov · Last updated 22 Mar 2024
Brief summary (registry, in English)
Overweight and obesity are chronic non-communicable diseases with a rapidly increasing global prevalence. They constitute risk factors for various chronic conditions, including cardiovascular diseases, type 2 diabetes, chronic kidney disease, cancer, as well as musculoskeletal disorders and numerous other disorders, significantly impacting the quality of life. Numerous non-pharmacological interventions have been employed in the management of these conditions. Particularly, Auricular acupuncture (AA) has been a widely used and established method for weight management, owing to its effectiveness, safety, and convenience. Recently, a novel therapy known as Thread embedding acupuncture (TEA) has also demonstrated efficacy in weight reduction. Several studies have shown a substantial increase in treatment effectiveness when combining TEA with other acupuncture therapies. However, there is currently no available data on the combination of TEA with AA. This study is conducted to assess the efficacy and safety of combining TEA with AA compared with AA monotherapy in overweight and obesity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 12 Oct 2023
- Start date
- 30 Oct 2023
- Primary completion date
- 21 Mar 2024
- Lead sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Diseases
- Obesity
- NCT number
- NCT06091761
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From 30 Oct 2023 to the primary completion date, 21 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent participation in other clinical trials or utilization of other weight reduction therapies.
Other illness
- Secondary obesity resulting from endocrine diseases or medication.
- Presence of severe medical conditions (e.g., cardiovascular, hepatic, renal or others) that could potentially affect treatment outcomes as per researchers' assessments.
- Current use of weight-affecting medications, including diabetes medications, endocrine medications, and medications for neurological psychiatric disorders.
- Severe mental and neurological conditions that may impact treatment compliance.
- History of hypersensitivity reactions to any form of acupuncture with needles or to Polydioxanone.
Other
- Pregnancy, lactation, or recent childbirth within the past 6 months.
- Alcohol or substance addiction.
- Existing injuries or lesions at the acupoints under investigation in this study.
Who the study is looking for
- Simple overweight or obesity with a Body Mass Index (BMI) of 23 kg/m2 or higher, following the criteria of The World Health Organization Regional Office for the Western Pacific Region.
- Waist circumference of 90 cm or more for males, or 80 cm or more for females.
- Voluntary informed consent.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Medical Center HCMC - Branch no.3 Coordinator of this site? Confirm its status | Ho Chi Minh City | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.